TWD 59.6
(5.86%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -4.2 Billion TWD | -65.13% |
2022 | -2.54 Billion TWD | -9.64% |
2021 | -2.32 Billion TWD | 18.48% |
2020 | -2.84 Billion TWD | -26.42% |
2019 | -2.25 Billion TWD | 33.88% |
2018 | -3.4 Billion TWD | -52.73% |
2017 | -2.23 Billion TWD | -116.18% |
2016 | -1.03 Billion TWD | 58.09% |
2015 | -2.46 Billion TWD | -220.66% |
2014 | 2.04 Billion TWD | 304.25% |
2013 | -999.12 Million TWD | -9.28% |
2012 | -914.27 Million TWD | 60.82% |
2011 | -2.33 Billion TWD | 52.73% |
2010 | -4.93 Billion TWD | 20.05% |
2009 | -6.17 Billion TWD | -114.62% |
2008 | -2.87 Billion TWD | 50.36% |
2007 | -5.79 Billion TWD | 35.93% |
2006 | -9.04 Billion TWD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -5.43 Billion TWD | -11.84% |
2024 Q1 | -4.86 Billion TWD | -15.69% |
2023 FY | -4.2 Billion TWD | -65.13% |
2023 Q1 | -2.99 Billion TWD | -17.61% |
2023 Q3 | -4.48 Billion TWD | 16.45% |
2023 Q4 | -4.2 Billion TWD | 6.25% |
2023 Q2 | -5.36 Billion TWD | -79.25% |
2022 Q2 | -3.84 Billion TWD | -5.17% |
2022 Q4 | -2.54 Billion TWD | -100.5% |
2022 Q1 | -3.65 Billion TWD | -57.65% |
2022 FY | -2.54 Billion TWD | -9.64% |
2022 Q3 | -1.26 Billion TWD | 67.02% |
2021 Q3 | -1.98 Billion TWD | 46.1% |
2021 FY | -2.32 Billion TWD | 18.48% |
2021 Q1 | -2.09 Billion TWD | 26.32% |
2021 Q4 | -2.32 Billion TWD | -17.05% |
2021 Q2 | -3.67 Billion TWD | -75.36% |
2020 Q4 | -2.84 Billion TWD | 12.12% |
2020 Q3 | -3.24 Billion TWD | -98.14% |
2020 Q2 | -1.63 Billion TWD | 19.18% |
2020 Q1 | -2.02 Billion TWD | 10.17% |
2020 FY | -2.84 Billion TWD | -26.42% |
2019 Q2 | -3.47 Billion TWD | -53.75% |
2019 FY | -2.25 Billion TWD | 33.88% |
2019 Q4 | -2.25 Billion TWD | -13.06% |
2019 Q3 | -1.99 Billion TWD | 42.69% |
2019 Q1 | -2.26 Billion TWD | 33.63% |
2018 Q2 | -2.71 Billion TWD | 8.01% |
2018 Q3 | -3.54 Billion TWD | -30.68% |
2018 FY | -3.4 Billion TWD | -52.73% |
2018 Q1 | -2.94 Billion TWD | -32.2% |
2018 Q4 | -3.4 Billion TWD | 3.89% |
2017 Q3 | -908.9 Million TWD | 30.95% |
2017 Q4 | -2.23 Billion TWD | -145.43% |
2017 FY | -2.23 Billion TWD | -116.18% |
2017 Q1 | -3.46 Billion TWD | -235.84% |
2017 Q2 | -1.31 Billion TWD | 62.02% |
2016 Q2 | -478.48 Million TWD | 36.26% |
2016 FY | -1.03 Billion TWD | 58.09% |
2016 Q4 | -1.03 Billion TWD | -1.47% |
2016 Q3 | -1.01 Billion TWD | -112.55% |
2016 Q1 | -750.69 Million TWD | 69.51% |
2015 FY | -2.46 Billion TWD | -220.66% |
2015 Q2 | 88.72 Million TWD | -89.21% |
2015 Q1 | 822.61 Million TWD | -59.69% |
2015 Q3 | -1.8 Billion TWD | -2135.86% |
2015 Q4 | -2.46 Billion TWD | -36.31% |
2014 Q1 | -511.29 Million TWD | 48.83% |
2014 Q3 | 2.62 Billion TWD | 1954.21% |
2014 Q2 | -141.3 Million TWD | 72.36% |
2014 FY | 2.04 Billion TWD | 304.25% |
2014 Q4 | 2.04 Billion TWD | -22.12% |
2013 Q3 | -483.12 Million TWD | 81.76% |
2013 Q4 | -999.12 Million TWD | -106.81% |
2013 FY | -999.12 Million TWD | -9.28% |
2013 Q1 | -2.48 Billion TWD | -171.88% |
2013 Q2 | -2.64 Billion TWD | -6.54% |
2012 FY | -914.27 Million TWD | 60.82% |
2012 Q4 | -914.27 Million TWD | -1.95% |
2012 Q1 | -5.33 Billion TWD | -128.64% |
2012 Q3 | -896.79 Million TWD | 81.6% |
2012 Q2 | -4.87 Billion TWD | 8.63% |
2011 Q4 | -2.33 Billion TWD | 26.64% |
2011 Q1 | -5.91 Billion TWD | -19.91% |
2011 FY | -2.33 Billion TWD | 52.73% |
2011 Q3 | -3.18 Billion TWD | 35.61% |
2011 Q2 | -4.94 Billion TWD | 16.54% |
2010 Q4 | -4.93 Billion TWD | 0.0% |
2010 FY | -4.93 Billion TWD | 20.05% |
2009 FY | -6.17 Billion TWD | -114.62% |
2008 FY | -2.87 Billion TWD | 50.36% |
2007 FY | -5.79 Billion TWD | 35.93% |
2006 FY | -9.04 Billion TWD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Sinon Corporation | -38.98 Million TWD | -10681.524% |
All Cosmos Bio-Tech Holding Corporation | -1 Billion TWD | -319.561% |
CH Biotech R&D Co., Ltd. | -94.76 Million TWD | -4335.181% |